key: cord-1006162-kh0dno03 authors: Wu, Jing; Feng, Bo; Gao, Li-Xin; Zhang, Chun; Li, Jia; Xiang, Da-Jun; Zang, Yi; Wang, Wen-Long title: Synthesis and Biochemical Evaluation of 8H-Indeno[1,2-d]thiazole Derivatives as Novel SARS-CoV-2 3CL Protease Inhibitors date: 2022-05-23 journal: Molecules DOI: 10.3390/molecules27103359 sha: 891033d60c5eed0782ecac197c2a88670e9c98b2 doc_id: 1006162 cord_uid: kh0dno03 The COVID-19 pandemic caused by SARS-CoV-2 is a global burden on human health and economy. The 3-Chymotrypsin-like cysteine protease (3CL(pro)) becomes an attractive target for SARS-CoV-2 due to its important role in viral replication. We synthesized a series of 8H-indeno[1,2-d]thiazole derivatives and evaluated their biochemical activities against SARS-CoV-2 3CL(pro). Among them, the representative compound 7a displayed inhibitory activity with an IC(50) of 1.28 ± 0.17 μM against SARS-CoV-2 3CL(pro). Molecular docking of 7a against 3CL(pro) was performed and the binding mode was rationalized. These preliminary results provide a unique prototype for the development of novel inhibitors against SARS-CoV-2 3CL(pro). The global pandemic of coronavirus disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posted major challenges to public health systems and the economy worldwide [1] [2] [3] [4] [5] . There have been 434 million confirmed cases of COVID-19 worldwide as of the end of February 2022, and almost 6 million deaths have been reported [6] . Although multiple effective vaccines against COVID-19 are available, reinfections and breakthrough infections are frequently reported [7, 8] . In addition, the virus is continuing to evolve, and a new variant named Omicron enables the virus to evade the immune protective barrier due to a large number of mutations in the receptor binding sites [9] [10] [11] . Therefore, it is urgent to develop effective drugs and specific treatments for people who are infected by COVID-19 with severe symptoms. 3CL pro (also called M pro ) plays an essential role during replication and transcription of SARS-CoV-2 and has been regarded as an attractive target for treating COVID-19 and other coronavirus-caused diseases [12] [13] [14] . The development of 3CL pro inhibitors has attracted much attention from medicinal chemists and the pharmaceutical industry. The collective efforts culminated in the recent approval of Paxlovid (nirmatrelvir) by FDA for the treatment of SARS-CoV-2 [15] . As shown in Figure 1 , Most known 3CL pro inhibitors are In pursuit of novel 3CL pro inhibitors, we identified 8H-indeno[1,2-d]thiazole derivative 4 as a novel SARS-CoV-2 3CL pro inhibitor (IC50 = 6.42 ± 0.90 μM) through highthroughput screening of our compound collection ( Figure 2 ). This result provided us with an opportunity to explore novel small molecule inhibitors against SARS-CoV-2 3CL pro . Herein, we designed and synthesized a series of 8H-indeno[1,2-d]thiazole derivatives, evaluated their inhibitory activities against SARS-CoV-2 3CL pro , and elucidated the SARs. Selected compound 7a was subjected to molecular docking to predict the binding mode with SARS-CoV-2 3CL pro . In pursuit of novel 3CL pro inhibitors, we identified 8H-indeno[1,2-d]thiazole derivative 4 as a novel SARS-CoV-2 3CL pro inhibitor (IC 50 = 6.42 ± 0.90 µM) through high-throughput screening of our compound collection ( Figure 2 ). This result provided us with an opportunity to explore novel small molecule inhibitors against SARS-CoV-2 3CL pro . Herein, we designed and synthesized a series of 8H-indeno[1,2-d]thiazole derivatives, evaluated their inhibitory activities against SARS-CoV-2 3CL pro , and elucidated the SARs. Selected compound 7a was subjected to molecular docking to predict the binding mode with SARS-CoV-2 3CL pro . In pursuit of novel 3CL pro inhibitors, we identified 8H-indeno[1,2-d]thiazole derivative 4 as a novel SARS-CoV-2 3CL pro inhibitor (IC50 = 6.42 ± 0.90 μM) through highthroughput screening of our compound collection ( Figure 2 ). This result provided us with an opportunity to explore novel small molecule inhibitors against SARS-CoV-2 3CL pro . Herein, we designed and synthesized a series of 8H-indeno[1,2-d]thiazole derivatives, evaluated their inhibitory activities against SARS-CoV-2 3CL pro , and elucidated the SARs. Selected compound 7a was subjected to molecular docking to predict the binding mode with SARS-CoV-2 3CL pro . Based on the structure of compound 4, 14 new 8H-indeno[1,2-d]thiazole derivatives (compounds 7a-7l, and 10a-10b) (shown in Scheme 1 and Scheme 2) were designed and synthesized through a two-step synthesis from the appropriate ketone and thiourea [25, 26, 27, 28] . Adjusting the methoxy group of compound 4 from position 5 to position 6 Based on the structure of compound 4, 14 new 8H-indeno[1,2-d]thiazole derivatives (compounds 7a-7l, and 10a-10b) (shown in Schemes 1 and 2) were designed and synthesized through a two-step synthesis from the appropriate ketone and thiourea [25] [26] [27] [28] . Adjusting the methoxy group of compound 4 from position 5 to position 6 afforded compound 7a. Considering the effects of steric hindrance and electron withdrawing, compounds 7b-7e were synthesized by substitution of the methoxy group for the butoxy, isobutoxy, and methyl groups and for the chlorine atom. After replacing the 3,5-dimethoxybenzamido moiety in compound 7a with 3,4,5-trimethoxybenzamido, 3,5-diacetoxybenzamido, 3-methoxybenzamido, 3-fluorobenzamido, thiophene-2-carboxamido, and 4-chlorobenzamido, compounds 7f-7k were obtained. To evaluate the effect of ring expansion, compound 7l was synthesized. Finally, ring opening analogues 10a and 10b were synthesized to elucidate the effect of the central ring on the inhibition of 3CL pro . Based on the structure of compound 4, 14 new 8H-indeno[1,2-d]thiazole derivatives (compounds 7a-7l, and 10a-10b) (shown in Schemes 1 and 2) were designed and synthesized through a two-step synthesis from the appropriate ketone and thiourea [25] [26] [27] [28] . Adjusting the methoxy group of compound 4 from position 5 to position 6 afforded compound 7a. Considering the effects of steric hindrance and electron withdrawing, compounds 7b-7e were synthesized by substitution of the methoxy group for the butoxy, isobutoxy, and methyl groups and for the chlorine atom. After replacing the 3,5-dimethoxybenzamido moiety in compound 7a with 3,4,5-trimethoxybenzamido, 3,5-diacetoxybenzamido, 3-methoxybenzamido, 3-fluorobenzamido, thiophene-2-carboxamido, and 4chlorobenzamido, compounds 7f-7k were obtained. To evaluate the effect of ring expansion, compound 7l was synthesized. Finally, ring opening analogues 10a and 10b were synthesized to elucidate the effect of the central ring on the inhibition of 3CL pro . All synthesized compounds were evaluated for inhibitory activity against SARS-CoV-2 3CL pro using PF-07321332 as positive control [29] [30] [31] , and the results were detailed in Table 1 . We initially prepared 7a from the commercially available compound 5a by the route outlined in Scheme 1. We noticed that compound 7a with 6-methoxy group on the phenyl ring exhibited inhibitory activity against SARS-CoV-2 3CL pro with 1.28 ± 0.17 μM, about five times more potent than compound 4 with 5-methoxy group on the phenyl ring. The result indicated that the position of the methoxy group on the phenyl ring significantly affected inhibitory activities against SARS-CoV-2 3CL pro . To explore the SAR of this seemingly important position, methoxy group on compound 7a was replaced by butoxy (7b), isobutoxy (7c), methyl groups (7d), and chlorine atom (7e); the inhibitory activities of the corresponding compounds 7b-7e were completely abolished. These results Based on the structure of compound 4, 14 new 8H-indeno[1,2-d]thiazole derivatives (compounds 7a-7l, and 10a-10b) (shown in Schemes 1 and 2) were designed and synthesized through a two-step synthesis from the appropriate ketone and thiourea [25] [26] [27] [28] . Adjusting the methoxy group of compound 4 from position 5 to position 6 afforded compound 7a. Considering the effects of steric hindrance and electron withdrawing, compounds 7b-7e were synthesized by substitution of the methoxy group for the butoxy, isobutoxy, and methyl groups and for the chlorine atom. After replacing the 3,5-dimethoxybenzamido moiety in compound 7a with 3,4,5-trimethoxybenzamido, 3,5-diacetoxybenzamido, 3-methoxybenzamido, 3-fluorobenzamido, thiophene-2-carboxamido, and 4chlorobenzamido, compounds 7f-7k were obtained. To evaluate the effect of ring expansion, compound 7l was synthesized. Finally, ring opening analogues 10a and 10b were synthesized to elucidate the effect of the central ring on the inhibition of 3CL pro . All synthesized compounds were evaluated for inhibitory activity against SARS-CoV-2 3CL pro using PF-07321332 as positive control [29] [30] [31] , and the results were detailed in Table 1 . We initially prepared 7a from the commercially available compound 5a by the route outlined in Scheme 1. We noticed that compound 7a with 6-methoxy group on the phenyl ring exhibited inhibitory activity against SARS-CoV-2 3CL pro with 1.28 ± 0.17 μM, about five times more potent than compound 4 with 5-methoxy group on the phenyl ring. The result indicated that the position of the methoxy group on the phenyl ring significantly affected inhibitory activities against SARS-CoV-2 3CL pro . To explore the SAR of this seemingly important position, methoxy group on compound 7a was replaced by butoxy (7b), isobutoxy (7c), methyl groups (7d), and chlorine atom (7e); the inhibitory activities of the corresponding compounds 7b-7e were completely abolished. These results All synthesized compounds were evaluated for inhibitory activity against SARS-CoV-2 3CL pro using PF-07321332 as positive control [29] [30] [31] , and the results were detailed in Table 1 . We initially prepared 7a from the commercially available compound 5a by the route outlined in Scheme 1. We noticed that compound 7a with 6-methoxy group on the phenyl ring exhibited inhibitory activity against SARS-CoV-2 3CL pro with 1.28 ± 0.17 µM, about five times more potent than compound 4 with 5-methoxy group on the phenyl ring. The result indicated that the position of the methoxy group on the phenyl ring significantly affected inhibitory activities against SARS-CoV-2 3CL pro . To explore the SAR of this seemingly important position, methoxy group on compound 7a was replaced by butoxy (7b), isobutoxy (7c), methyl groups (7d), and chlorine atom (7e); the inhibitory activities of the corresponding compounds 7b-7e were completely abolished. These results demonstrated that the effect of steric hindrance at this position was detrimental to inhibitory activities. The SAR of R 3 was explored next. Replacement of the 3,5-dimethoxybenzamido moiety with 3,4,5-trimethoxybenzamido moiety, 3,5-diacetoxybenzamido moiety, 3-methoxybenzamido moiety, 3-fluorobenzamido moiety, thiophene-2-carboxamido moiety, and 4-chlorobenzamido moiety led to compounds 7f, 7g, 7h, 7i, 7j, and 7k, respectively. The inhibitory activity of compounds 7f and 7g dropped significantly, while compound 7h almost maintained its inhibitory activities. These results indicated that the extra steric hindrance had negative impact on the inhibitory activities. Compared to compound 7h, the inhibitory activities of compounds 7i-7k diminished; these results indicated that introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8H-indeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the five-membered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . demonstrated that the effect of steric hindrance at this position was detrimental to inhibitory activities. The SAR of R 3 was explored next. Replacement of the 3,5-dimethoxybenzamido moiety with 3,4,5-trimethoxybenzamido moiety, 3,5-diacetoxybenzamido moiety, 3-methoxybenzamido moiety, 3-fluorobenzamido moiety, thiophene-2-carboxamido moiety, and 4-chlorobenzamido moiety led to compounds 7f, 7g, 7h, 7i, 7j, and 7k, respectively. The inhibitory activity of compounds 7f and 7g dropped significantly, while compound 7h almost maintained its inhibitory activities. These results indicated that the extra steric hindrance had negative impact on the inhibitory activities. Compared to compound 7h, the inhibitory activities of compounds 7i-7k diminished; these results indicated that introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8Hindeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the fivemembered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . demonstrated that the effect of steric hindrance at this position was detrimental to inhibitory activities. The SAR of R 3 was explored next. Replacement of the 3,5-dimethoxybenzamido moiety with 3,4,5-trimethoxybenzamido moiety, 3,5-diacetoxybenzamido moiety, 3-methoxybenzamido moiety, 3-fluorobenzamido moiety, thiophene-2-carboxamido moiety, and 4-chlorobenzamido moiety led to compounds 7f, 7g, 7h, 7i, 7j, and 7k, respectively. The inhibitory activity of compounds 7f and 7g dropped significantly, while compound 7h almost maintained its inhibitory activities. These results indicated that the extra steric hindrance had negative impact on the inhibitory activities. Compared to compound 7h, the inhibitory activities of compounds 7i-7k diminished; these results indicated that introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8Hindeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the fivemembered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . demonstrated that the effect of steric hindrance at this position was detrimental to inhibitory activities. The SAR of R 3 was explored next. Replacement of the 3,5-dimethoxybenzamido moiety with 3,4,5-trimethoxybenzamido moiety, 3,5-diacetoxybenzamido moiety, 3-methoxybenzamido moiety, 3-fluorobenzamido moiety, thiophene-2-carboxamido moiety, and 4-chlorobenzamido moiety led to compounds 7f, 7g, 7h, 7i, 7j, and 7k, respectively. The inhibitory activity of compounds 7f and 7g dropped significantly, while compound 7h almost maintained its inhibitory activities. These results indicated that the extra steric hindrance had negative impact on the inhibitory activities. Compared to compound 7h, the inhibitory activities of compounds 7i-7k diminished; these results indicated that introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8Hindeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the fivemembered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . demonstrated that the effect of steric hindrance at this position was detrimental to inhibitory activities. The SAR of R 3 was explored next. Replacement of the 3,5-dimethoxybenzamido moiety with 3,4,5-trimethoxybenzamido moiety, 3,5-diacetoxybenzamido moiety, 3-methoxybenzamido moiety, 3-fluorobenzamido moiety, thiophene-2-carboxamido moiety, and 4-chlorobenzamido moiety led to compounds 7f, 7g, 7h, 7i, 7j, and 7k, respectively. The inhibitory activity of compounds 7f and 7g dropped significantly, while compound 7h almost maintained its inhibitory activities. These results indicated that the extra steric hindrance had negative impact on the inhibitory activities. Compared to compound 7h, the inhibitory activities of compounds 7i-7k diminished; these results indicated that introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8Hindeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the fivemembered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . demonstrated that the effect of steric hindrance at this position was detrimental to inhibitory activities. The SAR of R 3 was explored next. Replacement of the 3,5-dimethoxybenzamido moiety with 3,4,5-trimethoxybenzamido moiety, 3,5-diacetoxybenzamido moiety, 3-methoxybenzamido moiety, 3-fluorobenzamido moiety, thiophene-2-carboxamido moiety, and 4-chlorobenzamido moiety led to compounds 7f, 7g, 7h, 7i, 7j, and 7k, respectively. The inhibitory activity of compounds 7f and 7g dropped significantly, while compound 7h almost maintained its inhibitory activities. These results indicated that the extra steric hindrance had negative impact on the inhibitory activities. Compared to compound 7h, the inhibitory activities of compounds 7i-7k diminished; these results indicated that introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8Hindeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the fivemembered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . demonstrated that the effect of steric hindrance at this position was detrimental to inhibitory activities. The SAR of R 3 was explored next. Replacement of the 3,5-dimethoxybenzamido moiety with 3,4,5-trimethoxybenzamido moiety, 3,5-diacetoxybenzamido moiety, 3-methoxybenzamido moiety, 3-fluorobenzamido moiety, thiophene-2-carboxamido moiety, and 4-chlorobenzamido moiety led to compounds 7f, 7g, 7h, 7i, 7j, and 7k, respectively. The inhibitory activity of compounds 7f and 7g dropped significantly, while compound 7h almost maintained its inhibitory activities. These results indicated that the extra steric hindrance had negative impact on the inhibitory activities. Compared to compound 7h, the inhibitory activities of compounds 7i-7k diminished; these results indicated that introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8Hindeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the fivemembered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . demonstrated that the effect of steric hindrance at this position was detrimental to inhibitory activities. The SAR of R 3 was explored next. Replacement of the 3,5-dimethoxybenzamido moiety with 3,4,5-trimethoxybenzamido moiety, 3,5-diacetoxybenzamido moiety, 3-methoxybenzamido moiety, 3-fluorobenzamido moiety, thiophene-2-carboxamido moiety, and 4-chlorobenzamido moiety led to compounds 7f, 7g, 7h, 7i, 7j, and 7k, respectively. The inhibitory activity of compounds 7f and 7g dropped significantly, while compound 7h almost maintained its inhibitory activities. These results indicated that the extra steric hindrance had negative impact on the inhibitory activities. Compared to compound 7h, the inhibitory activities of compounds 7i-7k diminished; these results indicated that introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8Hindeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the fivemembered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . demonstrated that the effect of steric hindrance at this position was detrimental to inhibitory activities. The SAR of R 3 was explored next. Replacement of the 3,5-dimethoxybenzamido moiety with 3,4,5-trimethoxybenzamido moiety, 3,5-diacetoxybenzamido moiety, 3-methoxybenzamido moiety, 3-fluorobenzamido moiety, thiophene-2-carboxamido moiety, and 4-chlorobenzamido moiety led to compounds 7f, 7g, 7h, 7i, 7j, and 7k, respectively. The inhibitory activity of compounds 7f and 7g dropped significantly, while compound 7h almost maintained its inhibitory activities. These results indicated that the extra steric hindrance had negative impact on the inhibitory activities. Compared to compound 7h, the inhibitory activities of compounds 7i-7k diminished; these results indicated that introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8Hindeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the fivemembered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . introduction of an electron-withdrawing group or heterocyclic ring on the scaffold of 8Hindeno[1,2-d]thiazole took negative roles for inhibitory activities. Expanding the fivemembered ring on compound 7a to a six-membered ring led to compound 7l, which unfortunately did not show any inhibitory activity against SARS-CoV-2 3CL pro . Opening the five-membered ring on compound 7a resulted in compounds 10a and 10b, which also lost inhibitory activities. These results indicated that the five-membered ring on compound 7a is important for the inhibitory activity against SARS-CoV-2 3CL pro . To explore the interaction mode between small molecule 7a and 3CL pro (PDB code: 6M2N) [23] , we carried out molecular docking by applying AutoDock 4.2 program [31] [32] [33] [34] . Figure 3a showed that 7a docked well into the binding pockets S1 and S2 of 3CL pro , in which the S1, S2 sites play a key role in substrate recognition [35] . As illustrated in Figure 3b , the indene moiety of compound 7a buried deeply into the hydrophobic S2 subsite with π-electrons with Arg188 and hydrophobic interaction with Met165; the 3,5-dimethoxybenzamido moiety of compound 7a formed strong H-bonds with Asn142, Glu166 on S1 subsite, while compounds 4 and 7h escaped from S1 subsite, as shown in Supplementary Materials Figures S1 and S2. To explore the interaction mode between small molecule 7a and 3CL pro (PDB code: 6M2N) [23] , we carried out molecular docking by applying AutoDock 4.2 program [31] [32] [33] [34] . Figure 3a showed that 7a docked well into the binding pockets S1 and S2 of 3CL pro , in which the S1, S2 sites play a key role in substrate recognition [35] . As illustrated in Figure 3b , the indene moiety of compound 7a buried deeply into the hydrophobic S2 subsite with π-electrons with Arg188 and hydrophobic interaction with Met165; the 3,5-dimethoxybenzamido moiety of compound 7a formed strong H-bonds with Asn142, Glu166 on S1 subsite, while compounds 4 and 7h escaped from S1 subsite, as shown in Supplementary Materials Figures S1 and S2. To explore the interaction mode between small molecule 7a and 3CL pro (PDB code: 6M2N) [23] , we carried out molecular docking by applying AutoDock 4.2 program [31] [32] [33] [34] . Figure 3a showed that 7a docked well into the binding pockets S1 and S2 of 3CL pro , in which the S1, S2 sites play a key role in substrate recognition [35] . As illustrated in Figure 3b , the indene moiety of compound 7a buried deeply into the hydrophobic S2 subsite with π-electrons with Arg188 and hydrophobic interaction with Met165; the 3,5-dimethoxybenzamido moiety of compound 7a formed strong H-bonds with Asn142, Glu166 on S1 subsite, while compounds 4 and 7h escaped from S1 subsite, as shown in Supplementary Materials Figures S1 and S2. To explore the interaction mode between small molecule 7a and 3CL pro (PDB code: 6M2N) [23] , we carried out molecular docking by applying AutoDock 4.2 program [31] [32] [33] [34] . Figure 3a showed that 7a docked well into the binding pockets S1 and S2 of 3CL pro , in which the S1, S2 sites play a key role in substrate recognition [35] . As illustrated in Figure 3b , the indene moiety of compound 7a buried deeply into the hydrophobic S2 subsite with π-electrons with Arg188 and hydrophobic interaction with Met165; the 3,5-dimethoxybenzamido moiety of compound 7a formed strong H-bonds with Asn142, Glu166 on S1 subsite, while compounds 4 and 7h escaped from S1 subsite, as shown in Supplementary Materials Figures S1 and S2 To explore the interaction mode between small molecule 7a and 3CL pro (PDB code: 6M2N) [23] , we carried out molecular docking by applying AutoDock 4.2 program [31] [32] [33] [34] . Figure 3a showed that 7a docked well into the binding pockets S1 and S2 of 3CL pro , in which the S1, S2 sites play a key role in substrate recognition [35] . As illustrated in Figure 3b , the indene moiety of compound 7a buried deeply into the hydrophobic S2 subsite with π-electrons with Arg188 and hydrophobic interaction with Met165; the 3,5-dimethoxybenzamido moiety of compound 7a formed strong H-bonds with Asn142, Glu166 on S1 subsite, while compounds 4 and 7h escaped from S1 subsite, as shown in Supplementary Materials Figures S1 and S2 To explore the interaction mode between small molecule 7a and 3CL pro (PDB code: 6M2N) [23] , we carried out molecular docking by applying AutoDock 4.2 program [31] [32] [33] [34] . Figure 3a showed that 7a docked well into the binding pockets S1 and S2 of 3CL pro , in which the S1, S2 sites play a key role in substrate recognition [35] . As illustrated in Figure 3b , the indene moiety of compound 7a buried deeply into the hydrophobic S2 subsite with π-electrons with Arg188 and hydrophobic interaction with Met165; the 3,5-dimethoxybenzamido moiety of compound 7a formed strong H-bonds with Asn142, Glu166 on S1 subsite, while compounds 4 and 7h escaped from S1 subsite, as shown in Supplementary Materials Figures S1 and S2. 99.5 ± 0.1 0.012 ± 0.001 To explore the interaction mode between small molecule 7a and 3CL pro (PDB code: 6M2N) [23] , we carried out molecular docking by applying AutoDock 4.2 program [31] [32] [33] [34] . Figure 3a showed that 7a docked well into the binding pockets S1 and S2 of 3CL pro , in which the S1, S2 sites play a key role in substrate recognition [35] . As illustrated in Figure 3b , the indene moiety of compound 7a buried deeply into the hydrophobic S2 subsite with π-electrons with Arg188 and hydrophobic interaction with Met165; the 3,5-dimethoxybenzamido moiety of compound 7a formed strong H-bonds with Asn142, Glu166 on S1 subsite, while compounds 4 and 7h escaped from S1 subsite, as shown in Supplementary Materials Figures S1 and S2. Molecules 2022, 27, x FOR PEER REVIEW 6 of 12 Figure 3 . (a) surf representation of the compound 7a (bonds representation) in the 3CL pro S1 (red), S2 (blue), S1′ (green), S4 (orange) binding pocket; (b) the docking results of 7a and 3CL pro (PDB code: 6M2N, active residues in 3.0 Å range around 7a). Figure 3 . (a) surf representation of the compound 7a (bonds representation) in the 3CL pro S1 (red), S2 (blue), S1 (green), S4 (orange) binding pocket; (b) the docking results of 7a and 3CL pro (PDB code: 6M2N, active residues in 3.0 Å range around 7a). All chemical reagents are reagent grade and used as purchased. 1 H NMR (400 MHz) spectra were recorded on a Bruker AVIII 400 MHz spectrometer (Bruker, Billerica, MA, USA). The chemical shifts were reported in parts per million (ppm) using the 2.50 signal of DMSO ( 1 H NMR) and the 39.52 signal of DMSO ( 13 C NMR) as internal standards. ESI Mass spectra (MS) were obtained on a SHIMADZU 2020 Liquid Chromatograph Mass Spectrometer (SHIMADZU, Kyoto, Japan). 3.1.1. General Procedure for the Synthesis of Compounds 7a-7k (Exemplified by 7a) To a solution of 5a (6.2 mmol, 1.0 equiv) in dry ethanol (25 mL) were added thiourea (12.4 mmol, 2.0 equiv) and bromine (6.8 mmol, 1.1 equiv) at room temperature. The reaction solution was stirred at 100 • C for 5-6 h, At the end of the reaction, the solvent was evaporated, and aqueous ammonium hydroxide (25%) was added to the residue. The precipitated solid was collected without purification for the next step. The mixture of 6a (2.2 mmol, 1.1 equiv), aromatic acid (2.0 mmol, 1.0 equiv), HATU (2.0 mmol, 1.0 equiv), and DIPEA (6.0 mmol, 3.0 equiv) in DMF (15 mL) was stirred at room temperature for 2 h. The reaction mixture was quenched with water. The aqueous layer was extracted with EtOAc (30 mL × 2). The combined organic layers were dried over Na 2 SO 4 . The residue was purified by column chromatography on silica gel (eluting with DCM) to afford compound 7a as a yellow solid (280.0 mg, yield 37%). 1 13 ppm. 13 MS (ESI): m/z calcd for C 20 H 19 N 2 O 3 S [M + H] + 367.11, found 366.95. N-(6-chloro-8H-indeno[1,2-d]thiazol-2-yl)-3,5-dimethoxybenzamide (7e), eluting with DCM, yield = 39%; 1 H NMR (400 MHz, DMSO-d 6 ) δ 12.85 (s, 1H), 7.64 (d, J = 1.6 Hz, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.42 (dd, J = 8.0, 2.0 Hz, 1H), 7.33 (d, J = 2.0 Hz, 2H), 6.74 (t, J = 2.0 Hz, 1H), 3.94 (s, 2H), 3.84 (s, 6H) ppm. 13 C NMR (100 MHz, DMSO-d6) 80 (s, 3H), 2.33 (s, 6H) ppm. 13 C NMR (100 MHz, DMSO-d 6 ) found 439.05 3-methoxy-N-(6-methoxy-8H-indeno[1,2-d]thiazol-2-yl)benzamide (7h), eluting with DCM, yield = 47%; 1 H NMR (400 MHz, DMSO-d 6 ) δ 12.81 (s, 1H), 7.72-7.70 (m, 2H), 7.48-7.44 (m, 2H), 7.22-7.18 (m, 2H) MS (ESI): m/z calcd for C 19 H 17 N 2 O 3 S [M + H] + 353.10, found 353.15. 3-fluoro-N-(6-methoxy-8H-indeno[1,2-d]thiazol-2-yl)benzamide (7i), eluting with DCM, yield = 34%; 1 H NMR (400 MHz, DMSO-d 6 ) δ 12.92 (s, 1H), 8.00-7.94 (m, 2H), 7.65-7.59 (m, 1H) 87 (s, 2H), 3.80 (s, 3H) ppm. 13 C NMR (100 MHz, DMSO-d 6 ) 88 (s, 2H), 3.80 (s, 3H) ppm. 13 C NMR (100 MHz, DMSO-d 6 ) To a solution of 5f (528.2 mg, 3.0 mmol) in dry ethanol (10 mL) were added thiourea MS (ESI)found 385.20. 3,5-dimethoxy-N-(4-(4-methoxy-3-methylphenyl)thiazol-2-yl)benzamide (10b), eluting with DCM, yield = 40%; 1 H NMR (400 MHz A pneumonia outbreak associated with a new coronavirus of probable bat origin A novel coronavirus outbreak of global health concern A new coronavirus associated with human respiratory disease in China The species Severe acute respiratory syndromerelated coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2 Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections COVID-19 Vaccine Breakthrough Infections Reported to CDC-United States Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents Coronavirus biology and replication: Implications for SARS-CoV-2 Recent discovery and development of inhibitors targeting coronaviruses Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19a meta-analysis Novel Nitrile Peptidomimetics for Treating COVID-19 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro) Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients Discovery of 4 -O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor Synthesis and biological evaluation of 2-aminothiazoles and their amide derivatives on human adenosine receptors. Lack of effect of 2-aminothiazoles as allosteric enhancers Synthesis and Carbonic Anhydrase Inhibition of Novel 2-(4-(Aryl)thiazole-2-yl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-di one Derivatives 2-Aminothiazoles: A new class of agonist allosteric enhancers of A1 adenosine receptor 6-Aryl-8H-indeno[1,2-d]thiazol-2-ylamines: A1 Adenosine Receptor Agonist Allosteric Enhancers Having Improved Potency Reproductive and developmental safety of nirmatrelvir (PF-07321332), an oral SARS-CoV-2 M(pro) inhibitor in animal models Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332 Synthesis and biological evaluation of 2,5-diaryl-1,3,4-oxadiazole derivatives as novel Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) inhibitors AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility Design of wide-spectrum inhibitors targeting coronavirus main proteases Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease The authors express their gratitude to the BioDuro-Sundia in Wuxi for NMR spectral data and mass spectral data. The authors declare no conflict of interest.Sample Availability: Some of the compounds may be available in mg quantities upon request from the corresponding authors. The protease structure, SARS-CoV-2 3CL pro enzyme (PDB code: 6M2N) with 2.2 Å, was obtained from the the Protein Data Bank at the RCSB site (http://www.rcsb.org (accessed on 6 March 2022)). The molecule docking used the Lamarckian genetic algorithm local search method and the semiempirical free energy calculation method in the AutoDock 4.2 program. Additionally, the charge was added by Kollman in AutoDock 4.2, The docking methold was employed on rigid receptor conformation, all the rotatable torsional bonds of compound 7a were set free, the size of grid box was set at to 10.4 nm × 12.6 nm × 11.0 nm points with a 0.0375 nm spacing and grid center (−33.798 −46.566 39.065), and the other parameters were maintained at their default settings. The enzyme activity and inhibition assays of SARS-CoV-2 3CL pro have been described previously [20, 36] . Briefly, the recombinant SARS-CoV-2 3CL pro (40 nM at a final concentration) was mixed with each compound in 50 µL of assay buffer (20 mM Tris, pH 7.3, 150 mM NaCl, 1% Glycerol, 0.01% Tween-20) and incubated for 10 min. The reaction was initiated by adding the fluorogenic substrate MCA-AVLQSGFRK (DNP) K (GL Biochem, Shanghai, China), with a final concentration of 40 µM. After that, the fluorescence signal at 320 nm (excitation)/405 nm (emission) was immediately measured by continuous 10 points for 5 min with an EnVision multimode plate reader (Perkin Elmer, Waltham, MA, USA). The initial velocity was measured when the protease reaction was proceeding in a linear fashion; plots of fluorescence units versus time were fitted with linear regression to determine initial velocity. Plots of initial velocity versus inhibitor concentration were fitted using a four-parameter concentration-response model in GraphPad Prism 8 to calculate the IC 50 values. All data are shown as mean ± SD, n = 3 biological replicates. In summary, we synthesized a series of 8H-Indeno[1,2-d]thiazole derivatives and evaluated their biochemical activities against SARS-CoV-2 3CL pro . Among them, the representative compound 7a displayed inhibitory activity with an IC 50 of 1.28 ± 0.17 µM against SARS-CoV-2 3CL pro . Molecular docking elucidated that 7a was well-docked into the binding pockets S1 and S2 of 3CL pro . These preliminary results could provide a possible opportunity for the development of novel inhibitors against SARS-CoV-2 3CL pro with optimal potency and improved pharmacological properties. The following supporting information can be downloaded at: https: //www.mdpi.com/article/10.3390/molecules27103359/s1, copies of the 1 H NMR and 13 C NMR spectra for compounds 4, 7a-7l, 10a-10b and Figure S1 . surf representation of the compound 4 (bonds representation) in the 3CL pro S1 (red), S2 (blue), S1 (green), S4 (orange) binding pockets, Figure S2 . surf representation of the compound 7h (bonds representation) in the 3CL pro S1 (red), S2 (blue), S1 (green), S4 (orange) binding pockets.